The development of dry-powder inhaled montelukast formulations, continuous flow green chemistry API synthesis, and AI-driven respiratory disease modeling defines the future scope of the Montelukast Sodium Market. Inhaling LTRA formulations directly into the lungs delivers high local drug concentrations to bronchial tissues while minimizing systemic plasma exposure and neuropsychiatric risks. In...